Stanley Lau
Directeur/Membre du Conseil chez SOLASIA PHARMA K.K.
Profil
Stanley is a Special Advisor to Pappas Capital.
He is also CEO of TaiLai Biosciences, a Chinese biotechnology company providing a new generation of biopsy products and services based on its proprietary biomultiomics technology.
With over 40 years of business and healthcare experience, Stanley has served in a variety of senior roles in China and internationally with organizations including MSD, Baxter, Schering-Plough, China Biologic Products, Amsino Medical Group.
He currently serves as Non-Executive Chairman of the Board of Gland Pharma and as an independent director of Solasia Pharma K.K.
Postes actifs de Stanley Lau
| Sociétés | Poste | Début |
|---|---|---|
| SOLASIA PHARMA K.K. | Directeur/Membre du Conseil | - |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Consultant / Advisor | - |
Anciens postes connus de Stanley Lau
| Sociétés | Poste | Fin |
|---|---|---|
| GLAND PHARMA LIMITED | Président | - |
Formation de Stanley Lau
| University of London | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GLAND PHARMA LIMITED | Health Technology |
| SOLASIA PHARMA K.K. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Finance |
